We are glad to announce that Wojciech Winnicki has joined the Management Board of C&F.
The COVID-19 pandemic is a phenomenon that drastically impacted the functioning
of societies, markets and the business world all over the world. It keeps growing in scale,
and the effective curbing of the virus's spread is yet to come.
Companies have picked up the speed of the digitization process by three to four years, with the share of digital or digitally enabled products in their portfolios being accelerated by seven years. This rapid pace is perfectly justified, as an effective transformation into digital has become necessary for the survival of many companies.
Scientists are working on new ways to develop vaccines, with the so-called reverse vaccinology (or Vaccinology 3.0) being one of the main trends. This method of vaccine development is fast, but it requires screening the entire pathogen genome. It's a world of huge volumes of data.
We are happy to welcome Michael Mercurio to the C&F Team as Vice President of Client Services for the USA market. Michael’s mission will be to accelerate company growth within Life Sciences in the USA. Michael will strengthen our team to further develop relationships with our global customers, as we continue to expand C&F’s presence in the US.
M&As happen all the time, but the intensity of their occurrence is cyclic, as is the global economy. M&A numbers and values always grow significantly after the economy has experienced severe shocks. Knowing that, it only seems rational to expect a wave of these transactions after the coronavirus turmoil is over.
Building competitiveness by optimizing processes, increasing efficiency, and making decisions based on data obviously makes sense, and is a global trend. But let’s not forget about the good old price competition, and with it — tool sets necessary to carry out pricing policies effectively in globally competitive markets.
RegalixTV published an interview that Piotr Rudnicki gave to Justyna Sidor, a representative of the global business TV network RegalixTV.
The C&F Executive Team announced a new corporate operating structure consisting of the following business units: Life Science solutions, Data-Driven Innovation, Data Monetization, Risk & Compliance, and Lite Sourcing.